Singapore markets closed

EV Biologics, Inc. (YECO)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.6021-0.0200 (-3.21%)
At close: 09:59AM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 6.16M
Enterprise value 6.16M
Trailing P/E 0.01
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.38
Price/book (mrq)1.01
Enterprise value/revenue -0.25
Enterprise value/EBITDA 0.14

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-37.17%
S&P500 52-week change 322.38%
52-week high 31.9500
52-week low 30.5630
50-day moving average 30.6863
200-day moving average 31.0517

Share statistics

Avg vol (3-month) 3140
Avg vol (10-day) 3340
Shares outstanding 510.23M
Implied shares outstanding 610.23M
Float 81.09M
% held by insiders 10.00%
% held by institutions 10.00%
Shares short (30 Nov 2018) 491.37k
Short ratio (30 Nov 2018) 40.12
Short % of float (30 Nov 2018) 40.34%
Short % of shares outstanding (30 Nov 2018) 40.32%
Shares short (prior month 31 Oct 2018) 4251.3k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 309 Nov 2017
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2017
Most-recent quarter (mrq)30 Jun 2017

Profitability

Profit margin 0.00%
Operating margin (ttm)-18.95%

Management effectiveness

Return on assets (ttm)N/A
Return on equity (ttm)N/A

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)3.93
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA N/A
Net income avi to common (ttm)N/A
Diluted EPS (ttm)-1.2400
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.81M
Total cash per share (mrq)0.75
Total debt (mrq)11.85M
Total debt/equity (mrq)318.53%
Current ratio (mrq)N/A
Book value per share (mrq)1.54

Cash flow statement

Operating cash flow (ttm)N/A
Levered free cash flow (ttm)N/A